IpsiHand®
Clinical Services
Press Releases
Join Our Team
Contact Us

Press Releases

BCI Study Published in Stroke: Vascular and Interventional Neurology Confirms IpsiHand® Improves Motor Function After Stroke

August 18, 2026

First randomized controlled trial of an at-home, noninvasive BCI therapy for chronic stroke shows

Read More

Recent posts

Randomized Controlled Trial Demonstrated Positive Outcomes for FDA-Cleared Brain-Computer Interface IpsiHand® System in Chronic Stroke Rehabilitation

Feb 12, 2026

Randomized Controlled Trial Demonstrated Positive Outcomes for FDA-Cleared Brain-Computer Interface IpsiHand® System in Chronic Stroke Rehabilitation

Dr. Eric Leuthardt to Present Randomized Controlled Trial results on IpsiHand® at International Stroke Conference 2026

Feb 03, 2026

Dr. Eric Leuthardt to Present Randomized Controlled Trial results on IpsiHand® at International Stroke Conference 2026

Kandu, Inc. Announces Appointment of Marshal Linder to Board of Directors and Strategic Growth Investment from K2 HealthVentures and Piper Sandler Merchant Bank

Jan 12, 2026

Kandu, Inc. Announces Appointment of Marshal Linder to Board of Directors and Strategic Growth Investment from K2 HealthVentures and Piper Sandler Merchant Bank

Kandu, Inc. Announces Expansion of Executive Leadership Team and Board of Directors

Oct 20, 2025

Kandu, Inc. Announces Expansion of Executive Leadership Team and Board of Directors

Kandu Health and Neurolutions Merge to Form Kandu, Inc., a New Leader in Stroke Recovery

Apr 08, 2025

Kandu Health and Neurolutions Merge to Form Kandu, Inc., a New Leader in Stroke Recovery

Dual Milestone: Neurolutions, Inc Achieves MDSAP and ISO 13485 Certifications

Feb 04, 2025

Dual Milestone: Neurolutions, Inc Achieves MDSAP and ISO 13485 Certifications

Neurolutions, Inc. Announces Groundbreaking CMS Decision for IpsiHand®

Mar 12, 2024

Neurolutions, Inc. Announces Groundbreaking CMS Decision for IpsiHand®

Neurolutions Inc. and Kandu Health Announced Strategic Partnership to Accelerate Access to Breakthrough Brain Computer Interface (BCI) and Remote Support for Stroke Rehabilitation

Nov 08, 2023

Neurolutions Inc. and Kandu Health Announced Strategic Partnership to Accelerate Access to Breakthrough Brain Computer Interface (BCI) and Remote Support for Stroke Rehabilitation

Kandu Health Announces Preliminary Clinical Outcomes for Stroke Survivors

Jul 31, 2023

Kandu Health Announces Preliminary Clinical Outcomes for Stroke Survivors

Imperative Care Announces Three Senior Leadership Appointments for Kandu Health

Jun 14, 2023

Imperative Care Announces Three Senior Leadership Appointments for Kandu Health

Imperative Care Announces Formation of Stroke Recovery Digital Health Company Kandu Health

Feb 07, 2023

Imperative Care Announces Formation of Stroke Recovery Digital Health Company Kandu Health

Newly Published Studies Show Motor Recovery in Chronic Stroke Patients

Jul 05, 2022

Newly Published Studies Show Motor Recovery in Chronic Stroke Patients

Neurolutions Receives FDA De Novo Market Authorization for IpsiHand®

Apr 26, 2021

Neurolutions Receives FDA De Novo Market Authorization for IpsiHand®

Neurolutions IpsiHand® Stroke Rehabilitation Device Authorized by FDA

Apr 23, 2021

Neurolutions IpsiHand® Stroke Rehabilitation Device Authorized by FDA

Sign up for business updates

8085.1203.E

Join Our Team
Privacy Policy

© 2026 Kandu Health. All rights reserved.